A critical appraisal of the evidence for Botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome

Authors

Mehul J. Desai, George Washington UniversityFollow
Tatyana Shkolnikova
Andrew Nava
Danielle Inwald

Document Type

Journal Article

Publication Date

2-2014

Journal

Pain Practice : the Official Journal of the World Institute of Pain

Volume

Volume 14, Issue 2

Inclusive Pages

185-195

DOI

10.1111/papr.12074

Keywords

Botulinum Toxins, Type A--therapeutic use; Myofascial Pain Syndromes--drug therapy; Neuromuscular Agents--therapeutic use

APA Citation

Desai, M.J., Shkolnikova, T., Nava, A., Inwald, D. (2014). A critical appraisal of the evidence for botulinum toxin type a in the treatment for cervico-thoracic myofascial pain syndrome. Pain Practice, 14(2), 185-195.